ZIA KHAN: Open Payments
NPI 1427122092 · PEACHTREE CITY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 24 payments from 9 companies in 2025. Trend: 2023 $246 · 2024 $331 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $159 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Novo Nordisk Inc | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| Dexcom, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: REXULTI, ELIQUIS, Rybelsus, OTEZLA, VYNDAMAX, NURTEC ODT, Dexcom G6 Transmitter, BREZTRI.
Industry payments across GA — which companies pay providers there.
